Comparison of two antibiotic regimens (piperacillin plus amikacin versus ceftazidime plus amikacin) as empiric therapy for febrile neutropenic patients with cancer.

A total of 170 febrile episodes in neutropenic patients with cancer were randomly assigned to be treated with piperacillin-amikacin or ceftazidime-amikacin. The overall response rates were similar in both groups (68 and 65%, respectively). Response rates for clinically or microbiologically documente...

Full description

Saved in:

Bibliographic Details
Published in:	Antimicrob Agents Chemother
Main Authors:	Feliu, J, Artal, A, González Barón, M, Berrocal, A, Chacón, I, García de Paredes, M L, Espinosa, E, Ordóñez, A, Zamora, P, Montero, J M
Format:	Artigo
Language:	Inglês
Published:	American Society for Microbiology (ASM) 1992
Subjects:	Research Article
Online Access:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC245551/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1482151/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.36.12.2816
Tags:	Add Tag No Tags, Be the first to tag this record!

Comparison of two antibiotic regimens (piperacillin plus amikacin versus ceftazidime plus amikacin) as empiric therapy for febrile neutropenic patients with cancer.

Similar Items